YouTube8m· Nov 2023· cataloged

Rethinking ADHD Treatment: The Power of Non-Stimulant Medication


What this covers

In this eight-minute video, Dr. Tracey Marks works through why ADHD treatment built around stimulants leaves part of the problem untouched. She separates the core symptoms of attention, concentration, and distractibility, which Adderall and Ritalin handle well, from executive dysfunction: planning, time management, organization, emotion regulation, and set shifting. She notes that stimulants may help disorganization only indirectly, and only while the dose lasts. She also cautions that executive deficits are not unique to ADHD, and not everyone with ADHD has them.

The most distinctive section concerns interruptions. For someone with set-shifting problems, she argues, a 15-minute interruption can cost an hour or more of recovery and sink the rest of the day. She suggests stimulant-induced hyperfocus can make this worse, likening the break to a fast-moving train derailing, with no appropriate way to re-dose outside the schedule. Someone without these problems can pause, deal with the interruption, and resume.

The second half surveys the non-stimulant options: clonidine (Kapvay) and guanfacine (Intuniv), approved in 2009 and 2010 for children and adolescents only and often used as add-ons or for impulsivity, plus atomoxetine (Strattera) and viloxazine (Qelbree), approved in 2021. Both of the latter are norepinephrine reuptake inhibitors that must be taken daily. She cites a 2023 comparison finding viloxazine more effective and faster, with onset in about one to two weeks versus a month or more for atomoxetine. She reports that 85% of patients who added viloxazine to a stimulant were able to taper off the stimulant. She also flags that the executive-function study was done in children, and that insurers may require a failed atomoxetine trial before approving the brand-name drug.

Sharpest takeaway

Non-stimulant ADHD medications, particularly viloxazine (Qelbree), offer meaningful advantages for treating executive dysfunction that stimulants cannot adequately address, and may enable some patients to discontinue stimulants entirely.

  • Stimulants improve attention and focus but do not directly address executive dysfunction like planning, organization, time management, and set shifting
  • Viloxazine (Qelbree) showed superior efficacy to atomoxetine (Strattera) and significantly reduced executive function deficits in studies, with 85% of patients able to discontinue stimulants after stabilizing on Qelbree
  • Interruptions cause set-shifting problems that derail focus for hours even on stimulants, suggesting the need for different pharmacological approaches targeting norepinephrine systems

The claims · ranked42 claims · weighted by value

This asset isn't compiled yet

You're seeing its claims, ranked. Compile it to build the argument threads, weight them, and check each claim against your library — the full view.

0.81

Stimulant medications can paradoxically worsen set-shifting problems because the hyperfocus state they induce makes it difficult to mentally disengage from the current task when an interruption occurs.

causalhigh valueestablishednovelty 3/4durability 3/4· Dr. Tracey Marks

“Here's why a stimulant medication may not solve this problem. If you're on a stimulant, you may be in hyper focus mode where when you have to stop to have that quick call, you may have trouble letting go mentally from what you were doing and be unable to fully engage with the person to talk about something else.”

0.81

In a comparative study of Strattera versus Qelbree, 85% of patients who had Qelbree added to their stimulant medication were able to taper off the stimulant after stabilizing on Qelbree, indicating that Qelbree alone was sufficient for many patients.

factualhigh valueestablishednovelty 3/4durability 3/4· Dr. Tracey Marks

“Also, in this comparison study of Strattera versus Qelbree, of the people who had Qelbree added to their stimulant, 85% of them tapered off the stimulant after they were stabilized on Qelbree. That's a big deal to feel like Qelbree was enough to use all by itself and they no longer needed the stimulant.”

0.79

Work productivity in ADHD is more complex than typically understood because it requires addressing both core ADHD symptoms (attention, concentration) and executive functions (planning, organization, time management, emotion regulation, set shifting) simultaneously.

factualhigh valueestablishednovelty 2/4durability 3/4· Dr. Tracey Marks

“But some people will take a little more just so they can finish their work, and this is probably what is happening when as me as the doctor, I'll hear people tell me that the medicine seems to wear off too quickly in the afternoon... So all of this to say work productivity is more complex when you factor in executive functions.”

0.79

For people with set-shifting problems, a 15-minute interruption can destroy productivity for the entire rest of the day because it takes one hour or more to mentally shift away from distractions and refocus on the original task.

causalhigh valueestablishednovelty 2/4durability 3/4· Dr. Tracey Marks

“But for the person with problems with set shifting, and executive dysfunction is not exclusive to ADHD, and not everyone with ADHD struggles with this. But if you do, that 15 minute quick call can just ruin your productivity for the rest of the day. And yes, that sounds really dramatic, like the rest of your day, really? Yes, really. If you have this, you know what I'm talking about. When you return to your work, it takes so much work to shift your mind away from what you were just doing, or away from complete free flow mode where you're just thinking about a bunch of things that you need to do. By the time you settle down and refocus on the previous task, it may be an hour or more later, and now it's time for another interruption.”

0.76

Viloxazine (Qelbree) significantly reduced executive function deficits in a published study, though this study was conducted in children and the results may not fully generalize to adults.

factualhigh valueestablishednovelty 3/4durability 2/4· Dr. Tracey Marks

“Another study that I'll have linked in the description of this video showed that Qelbree significantly reduced executive function deficits. The caveat here is that this study was of children, and you can't always generalize those kinds of results to adults.”

0.75

In a comparison study of atomoxetine versus viloxazine, 85% of patients who had viloxazine added to their existing stimulant regimen were able to taper off the stimulant medication after stabilizing on viloxazine, indicating that viloxazine can be effective as monotherapy.

factualhigh valueestablishednovelty 2/4durability 3/4· Dr. Tracey Marks

“Also, in this comparison study of Strattera versus Qelbree, of the people who had Qelbree added to their stimulant, 85% of them tapered off the stimulant after they were stabilized on Qelbree. That's a big deal to feel like Qelbree was enough to use all by itself and they no longer needed the stimulant.”

0.75

When stimulant-induced hyperfocus is interrupted, the mental disruption is comparable to a fast-moving train derailing—the mind becomes jumbled and cannot easily return to the previous focus level, requiring another dose of medication to re-establish hyperfocus, which is not appropriate to take outside scheduled dosing times.

causalhigh valueestablishednovelty 2/4durability 3/4· Dr. Tracey Marks

“But even with the stimulant on board, the interruption pulls you out of hyperfocus, and that's enough to get you mentally jumbled. It's like being on a fast moving train that derails. The train can still move, but it's not good movement and the friction brings it to a stop. And similarly, when you're done, you're not going to get back to where you were, unless you take another pill, which you shouldn't do if it's not time for you to take another pill.”

0.75

Stimulant medications like Adderall and Ritalin work very well for attention, concentration, and distractibility, but they are not effective at directly improving executive functions like planning, time management, organization, and emotion regulation.

factualhigh valueestablishednovelty 2/4durability 3/4· Dr. Tracey Marks

“These medications work very well for attention, concentration, and distractibility, and hyperactivity, but they're not so great for directly improving the executive functions.”

0.75

Stimulants may only indirectly help with disorganization by improving focus temporarily, but once the medication wears off, the disorganization returns.

causalhigh valueestablishednovelty 2/4durability 3/4· Dr. Tracey Marks

“They may indirectly help, like if you're better able to stay focused without distractions, you may be better organized for that day, while the medication is working. But once the medication wears off, the disorganization returns.”

0.74

Executive dysfunction encompasses planning, time management, organization, emotion regulation, and set-shifting—the ability to switch attention between tasks and return to where one left off.

definitionhigh valueestablishednovelty 1/4durability 4/4· Dr. Tracey Marks

“you can think of executive dysfunction as things like planning, time management, organization, and even controlling your emotions. But another big one is called set shifting.”

0.74

Set shifting is the ability to switch attention between tasks and return to where you left off, and this ability is a core executive function.

definitionhigh valueestablishednovelty 1/4durability 4/4· Dr. Tracey Marks

“Set shifting is the ability to switch attention between tasks and then return to where you left off.”

0.74

A 2023 comparative study found that viloxazine (Qelbree) was more effective than atomoxetine (Strattera) and worked faster, showing effects within about one week for children and two weeks for adults.

factualhigh valueestablishednovelty 3/4durability 3/4· Dr. Tracey Marks

“Now we have viloxazine, Qelbree, and a recent 2023 study compared it directly to Strattera. The results were that Qelbree was more effective and worked faster, within about a week for children and two weeks for adults.”

0.70

Both atomoxetine and viloxazine function as norepinephrine reuptake inhibitors, increasing norepinephrine in the prefrontal cortex, which has a secondary effect of increasing dopamine and serotonin in this brain region.

factualhigh valueestablishednovelty 1/4durability 4/4· Dr. Tracey Marks

“Both medications are norepinephrine reuptake inhibitors, so they increase the amount of norepinephrine in the prefrontal cortex. This increased norepinephrine has a secondary effect of increasing dopamine and serotonin in this region of the brain.”

0.69

A 2023 study comparing viloxazine (Qelbree) directly to atomoxetine (Strattera) demonstrated that Qelbree was more effective and worked faster, with onset occurring within approximately one week for children and two weeks for adults.

factualhigh valueestablishednovelty 1/4durability 3/4· Dr. Tracey Marks

“Now we have viloxazine, Qelbree, and a recent 2023 study compared it directly to Strattera. The results were that Qelbree was more effective and worked faster, within about a week for children and two weeks for adults.”

0.69

Stimulant medications like Adderall and Ritalin do not directly address executive dysfunction symptoms such as disorganization, time management problems, and emotion dysregulation in ADHD patients, though they may indirectly help through improved focus while the medication is active.

factualhigh valueestablishednovelty 1/4durability 3/4· Dr. Tracey Marks

“If you have ADHD and executive dysfunction, like disorganization, time management problems, and emotion dysregulation, then you probably already know that the stimulants like Adderall and Ritalin don't do a lot to address these issues.”

0.69

For people without set-shifting problems, interruptions are manageable because they can pause one task, engage with the interruption, and resume the original task seamlessly without significant loss of focus or productivity.

factualhigh valueestablishednovelty 1/4durability 3/4· Dr. Tracey Marks

“For the person without a problem with set shifting, it's not a big deal. You just press pause, do the other thing, then unpress pause, and then it's like you never stopped.”

0.69

Executive dysfunction is not exclusive to ADHD, and not all people with ADHD experience set-shifting problems or other executive function deficits.

factualhigh valueestablishednovelty 1/4durability 3/4· Dr. Tracey Marks

“But for the person with problems with set shifting, and executive dysfunction is not exclusive to ADHD, and not everyone with ADHD struggles with this.”

0.69

Clonidine and guanfacine are typically used as second-choice medications for children who cannot tolerate stimulants or as add-on agents to enhance stimulant effects, and may be a good choice specifically for targeting impulsivity.

factualhigh valueestablishednovelty 1/4durability 3/4· Dr. Tracey Marks

“still are seen as second choices to stimulants for children who can't tolerate stimulants, or the doctors may use them to add to their stimulant regimen to enhance the effect. They also may be a good choice if you're trying to target impulsivity in a child or adolescent.”

0.65

Atomoxetine (Strattera) and viloxazine (Qelbree) are both norepinephrine reuptake inhibitors that work by increasing norepinephrine in the prefrontal cortex, which secondarily increases dopamine and serotonin in that brain region.

factualhigh valueestablishednovelty 1/4durability 3/4· Dr. Tracey Marks

“Both medications are norepinephrine reuptake inhibitors, so they increase the amount of norepinephrine in the prefrontal cortex. This increased norepinephrine has a secondary effect of increasing dopamine and serotonin in this region of the brain.”

0.64

Viloxazine (Qelbree) is still a brand-name medication, which may require insurance authorization from a doctor and some insurance companies require that patients fail a trial of atomoxetine (Strattera) before they will approve coverage for viloxazine.

factualhigh valueestablishednovelty 1/4durability 2/4· Dr. Tracey Marks

“Qelbree is still a brand drug, so your doctor may need to complete an insurance authorization in order for your insurance to pay for it. Some insurances will require that you try and fail Strattera before they will pay for Qelbree.”

0.63

There are currently four available non-stimulant medications for ADHD: clonidine (Kapvay), guanfacine (Intuniv), atomoxetine (Strattera), and viloxazine (Qelbree), the latter approved in 2021.

factualhigh valueestablishednovelty 0/4durability 3/4· Dr. Tracey Marks

“Currently, there are four available non-stimulant medications, clonidine, brand name, Kapvay, guanfacine, brand name Intuniv, atomoxetine, brand name Strattera and the latest one approved in 2021, viloxazine, brand name Qelbree.”

0.63

Unlike stimulants, both atomoxetine and viloxazine must be taken daily and have different onset profiles: atomoxetine requires a month or more to reach full effect, while viloxazine shows efficacy within one week for children and two weeks for adults.

factualhigh valueestablishednovelty 0/4durability 3/4· Dr. Tracey Marks

“Unlike stimulants, Strattera and Qelbree have to be taken daily. Strattera can take a month or more to see a good effect.”

0.63

Clonidine extended-release was FDA-approved in 2009 and guanfacine in 2010, and both were only approved for children and adolescents with ADHD, not for adults.

factualhigh valueestablishednovelty 0/4durability 3/4· Dr. Tracey Marks

“Clonidine extended release was FDA approved in 2009, and guanfacine in 2010. They were only approved though for children and adolescents with ADHD, and still are seen as second choices to stimulants for children who can't tolerate stimulants”

0.61

Unlike stimulants, atomoxetine (Strattera) and viloxazine (Qelbree) must be taken daily because they require consistent dosing to maintain their effects.

factualhigh valueestablishednovelty 1/4durability 3/4· Dr. Tracey Marks

“Unlike stimulants, Strattera and Qelbree have to be taken daily.”

0.61

Atomoxetine (Strattera) can take a month or more to reach good therapeutic effect.

factualhigh valueestablishednovelty 1/4durability 3/4· Dr. Tracey Marks

“Strattera can take a month or more to see a good effect.”

0.57

Viloxazine (Qelbree) is still a brand-name medication, which means doctors often need to complete insurance authorizations for coverage, and some insurances require patients to try and fail atomoxetine (Strattera) first before approving viloxazine.

factualhigh valueestablishednovelty 0/4durability 2/4· Dr. Tracey Marks

“Qelbree is still a brand drug, so your doctor may need to complete an insurance authorization in order for your insurance to pay for it. Some insurances will require that you try and fail Strattera before they will pay for Qelbree.”

0.57

When patients report that stimulant medication seems to wear off too quickly in the afternoon, this may not be due to dose being too low or developing tolerance, but rather because interruptions have caused loss of focus from which they cannot recover due to set-shifting problems.

causalhigh valuespeaker onlynovelty 3/4durability 3/4· Dr. Tracey Marks

“That wearing off may be because that the dose is too low, or you're becoming tolerant, so it's wearing off. Or it could be because interruptions have caused you to lose your focus, and you can't get it back because of trouble with set shifting.”

0.55

Atomoxetine (Strattera) was the first non-stimulant medication approved for ADHD in both children and adults in 2002, making it over 20 years old as a treatment option.

factualhigh valueestablishednovelty 0/4durability 3/4· Dr. Tracey Marks

“Atomoxetine, Strattera, was actually the first non-stimulant approved for ADHD in children and adults in 2002. So it's over 20 years old.”

0.52

A research study demonstrated that viloxazine (Qelbree) significantly reduced executive function deficits in children, though the caveat is that these results may not always generalize to adults; however, the pharmacological profile suggesting improvement in executive dysfunction is promising enough to warrant clinical trials in adults.

factualhigh valuespeaker onlynovelty 2/4durability 3/4· Dr. Tracey Marks

“Another study that I'll have linked in the description of this video showed that Qelbree significantly reduced executive function deficits. The caveat here is that this study was of children, and you can't always generalize those kinds of results to adults. But the fact that the profile of the drug shows that it improves executive dysfunction in children is promising and worth trying to use it for this purpose in adults.”

0.52

For people with set-shifting difficulties, a single 15-minute interruption can damage productivity for the entire day because the time required to regain focus on the previous task may take an hour or more, creating a cascade of inefficiency if further interruptions occur.

causalhigh valuespeaker onlynovelty 2/4durability 3/4· Dr. Tracey Marks

“that 15 minute quick call can just ruin your productivity for the rest of the day. And yes, that sounds really dramatic, like the rest of your day, really? Yes, really. If you have this, you know what I'm talking about.”

0.52

Stimulant medications can paradoxically impair set-shifting by placing patients in hyperfocus mode, causing difficulty disengaging from the current task when an interruption occurs, and even after the interruption, the hyperfocus state is disrupted such that re-engaging with the original task is extremely difficult without additional medication.

causalhigh valuespeaker onlynovelty 2/4durability 3/4· Dr. Tracey Marks

“Here's why a stimulant medication may not solve this problem. If you're on a stimulant, you may be in hyper focus mode where when you have to stop to have that quick call, you may have trouble letting go mentally from what you were doing and be unable to fully engage with the person to talk about something else.”

0.52

When patients report that stimulant medication seems to wear off too quickly in the afternoon, this may be attributed to one of three causes: insufficient dosage, tolerance development, or loss of focus due to interruptions and set-shifting difficulties that cannot be recovered without additional medication.

causalhigh valuespeaker onlynovelty 2/4durability 3/4· Dr. Tracey Marks

“That wearing off may be because the dose is too low, or you're becoming tolerant, so it's wearing off. Or it could be because interruptions have caused you to lose your focus, and you can't get it back because of trouble with set shifting.”

0.52

Some patients with ADHD take additional stimulant doses outside their prescribed schedule in an attempt to re-establish focus after interruptions have broken their hyperfocus, even though this is not clinically appropriate.

factualhigh valuespeaker onlynovelty 2/4durability 3/4· Dr. Tracey Marks

“But some people will take a little more just so they can finish their work, and this is probably what is happening when as me as the doctor, I'll hear people tell me that the medicine seems to wear off too quickly in the afternoon.”

0.52

The pharmacological profile of viloxazine shows promise for improving executive dysfunction in adults based on its demonstrated efficacy in children, making it worth trying for this purpose clinically despite the lack of direct adult-based evidence.

normativehigh valuespeaker onlynovelty 2/4durability 3/4· Dr. Tracey Marks

“But the fact that the profile of the drug shows that it improves executive dysfunction in children is promising and worth trying to use it for this purpose in adults.”

0.50

There are currently four FDA-approved non-stimulant medications for ADHD: clonidine (Kapvay), guanfacine (Intuniv), atomoxetine (Strattera), and viloxazine (Qelbree, approved in 2021).

factualhigh valueestablishednovelty 0/4durability 2/4· Dr. Tracey Marks

“Currently, there are four available non-stimulant medications, clonidine, brand name, Kapvay, guanfacine, brand name Intuniv, atomoxetine, brand name Strattera and the latest one approved in 2021, viloxazine, brand name Qelbree.”

0.48

Based on Dr. Marks' clinical experience prescribing atomoxetine to adult patients, the results were inconsistent or mediocre, with stimulants consistently demonstrating superior efficacy and faster onset.

factualhigh valuespeaker onlynovelty 1/4durability 3/4· Dr. Tracey Marks

“In my experience prescribing it, the results for my adult patients was just kind of so-so. The stimulants always seemed to work better and faster.”

0.47

Work productivity in ADHD is more complex than simply improving attention; it requires addressing executive function deficits through targeted pharmacological intervention.

factualhigh valuespeaker onlynovelty 2/4durability 3/4· Dr. Tracey Marks

“But some people will take a little more just so they can finish their work, and this is probably what is happening when as me as the doctor, I'll hear people tell me that the medicine seems to wear off too quickly in the afternoon. That wearing off may be because that the dose is too low, or you're becoming tolerant, so it's wearing off. Or it could be because interruptions have caused you to lose your focus, and you can't get it back because of trouble with set shifting. So all of this to say work productivity is more complex when you factor in executive functions.”

0.45

Based on Dr. Marks' clinical experience, atomoxetine (Strattera) produced only so-so results in adult patients, with stimulants always seeming to work better and faster.

factualhigh valuespeaker onlynovelty 1/4durability 2/4· Dr. Tracey Marks

“It's also been used for people who can't tolerate stimulants, or as an add-on to the stimulant. In my experience prescribing it, the results for my adult patients was just kind of so-so. The stimulants always seemed to work better and faster.”

0.43

Executive dysfunction is not exclusive to ADHD and not all individuals with ADHD struggle with set-shifting deficits.

factualestablishednovelty 1/4durability 3/4· Dr. Tracey Marks

“and executive dysfunction is not exclusive to ADHD, and not everyone with ADHD struggles with this.”

0.37

Atomoxetine (Strattera) was the first non-stimulant medication approved for ADHD in both children and adults in 2002, making it over 20 years old, and has been used as an alternative for patients intolerant of stimulants or as an adjunctive therapy.

factualestablishednovelty 0/4durability 3/4· Dr. Tracey Marks

“Atomoxetine, Strattera, was actually the first non-stimulant approved for ADHD in children and adults in 2002. So it's over 20 years old. It's also been used for people who can't tolerate stimulants, or as an add-on to the stimulant.”

0.37

Clonidine extended-release was FDA approved in 2009 and guanfacine in 2010, both only for children and adolescents with ADHD, where they are typically considered second-line choices for patients who cannot tolerate stimulants or as adjunctive therapy to enhance stimulant effects.

factualestablishednovelty 0/4durability 3/4· Dr. Tracey Marks

“Clonidine extended release was FDA approved in 2009, and guanfacine in 2010. They were only approved though for children and adolescents with ADHD, and still are seen as second choices to stimulants for children who can't tolerate stimulants, or the doctors may use them to add to their stimulant regimen to enhance the effect.”

0.35

Clonidine and guanfacine may be particularly useful for targeting impulsivity in children and adolescents with ADHD.

factualestablishednovelty 1/4durability 3/4· Dr. Tracey Marks

“They also may be a good choice if you're trying to target impulsivity in a child or adolescent.”